← Leaderboards
Sidney Michael Hecht
University Of Virginia Charlottesville
$6,822,120
Attributed
$6,822,120
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $829.7K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$11,121,080 · 7
By mechanism
R01$6,525,584 · 4
U19$4,595,496 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Joyce L Hamlin$10,699,349
- Alda Tufro$7,351,512
- Randall Johnson$148,268
- Chinghai Kao$3,858,376
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsEnzyme InhibitorsPlant ExtractsDrug Screening /EvaluationDna DamageBleomycinDna TopoisomerasesTransfer RnaDrug Design /Synthesis /ProductionDihydrofolate ReductaseIntermolecular InteractionAquatic OrganismDna Directed Dna PolymeraseLuciferin MonooxygenasePharmacokineticsBiological ProductsCombinatorial ChemistrySynthetic EnzymeAminoacid AnalogNeoplasm /Cancer PharmacologyPeptide Chemical SynthesisAcylationDrug InteractionsAntineoplastic Antibiotics
Grant awards (41)
Elaboration of Modified Proteins Using Misacylated tRNAs$293,216
R01 · FY2007 · CA · contact PI
Synthesis of Bleomycin Group Antibiotics and Analogues$250,059
R01 · FY2007 · CA · contact PI
Elaboration of Modified Proteins Using Misacylated tRNAs$302,017
R01 · FY2006 · CA · contact PI
Synthesis of Bleomycin Group Antibiotics and Analogues$257,528
R01 · FY2006 · CA · contact PI
Interaction of Bleomycin with RNA and DNA$252,914
R01 · FY2006 · CA · contact PI
Elaboration of Modified Proteins Using Misacylated tRNAs$309,328
R01 · FY2005 · CA
Synthesis of Bleomycin Group Antibiotics and Analogues$263,725
R01 · FY2005 · CA
Interaction of Bleomycin with RNA and DNA$256,600
R01 · FY2005 · CA
NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE$969,858
U19 · FY2004 · CA
Elaboration of Modified Proteins Using Misacylated tRNAs$309,370
R01 · FY2004 · CA
Synthesis of Bleomycin Group Antibiotics and Analogues$262,880
R01 · FY2004 · CA
Interaction of Bleomycin with RNA and DNA$251,800
R01 · FY2004 · CA
NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE$927,749
U19 · FY2003 · CA
Elaboration of Modified Proteins Using Misacylated tRNAs$300,386
R01 · FY2003 · CA
Synthesis of Bleomycin Group Antibiotics and Analogues$262,880
R01 · FY2003 · CA
Interaction of Bleomycin with RNA and DNA$247,000
R01 · FY2003 · CA
MECHANISM AND INHIBITION OF HUMAN DNA TOPOISOMERASE I$195,007
R01 · FY2003 · CA
NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE$916,274
U19 · FY2002 · CA
ELABORATION OF MODIFIED PROTEINS USING MISACYLATED TRNAS$277,461
R01 · FY2002 · CA
Interaction of Bleomycin with RNA and DNA$239,800
R01 · FY2002 · CA
MECHANISM AND INHIBITION OF HUMAN DNA TOPOISOMERASE I$189,931
R01 · FY2002 · CA
ELABORATION OF MODIFIED PROTEINS USING MISACYLATED TRNAS$30,802
R01 · FY2002 · CA
NUCLEAR TARGETS FOR NATURAL PRODUCTS DRUG DISCOVERY$0
U19 · FY2002 · CA
CORE--PREPARATION, STORAGE, AND SHIPPING OF PLANT EXTRACTS AND ASSAYS$0
U19 · FY2002 · CA
NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE$876,342
U19 · FY2001 · CA
ELABORATION OF MODIFIED PROTEINS USING MISACYLATED TRNAS$269,459
R01 · FY2001 · CA
INTERACTION OF BLEOMYCIN WITH RNA AND DNA$206,914
R01 · FY2001 · CA
SYNTHESIS OF BLEOMYCIN GROUP ANTIBIOTICS AND ANALOGUES$206,295
R01 · FY2001 · CA
MECHANISM AND INHIBITION OF HUMAN DNA TOPOISOMERASE I$183,198
R01 · FY2001 · CA
ELABORATION OF MODIFIED PROTEINS USING MISACYLATED TRNAS$30,034
R01 · FY2001 · CA
NUCLEAR TARGETS FOR NATURAL PRODUCTS DRUG DISCOVERY$0
U19 · FY2001 · CA
CORE--PREPARATION, STORAGE, AND SHIPPING OF PLANT EXTRACTS AND ASSAYS$0
U19 · FY2001 · CA
NATURAL PRODUCTS DISCOVERY - NUCLEAR AND SIGNALING TARGE$533,165
U19 · FY2000 · CA
ELABORATION OF MODIFIED PROTEINS USING MISACYLATED TRNAS$261,688
R01 · FY2000 · CA
INTERACTION OF BLEOMYCIN WITH RNA AND DNA$201,871
R01 · FY2000 · CA
SYNTHESIS OF BLEOMYCIN GROUP ANTIBIOTICS AND ANALOGUES$200,362
R01 · FY2000 · CA
MECHANISM AND INHIBITION OF HUMAN DNA TOPOISOMERASE I$183,771
R01 · FY2000 · CA
NUCLEAR TARGETS FOR NATURAL PRODUCTS DRUG DISCOVERY$148,268
U19 · FY2000 · CA
CORE--PREPARATION, STORAGE, AND SHIPPING OF PLANT EXTRACTS AND ASSAYS$148,268
U19 · FY2000 · CA
NATURAL PRODUCTS DISCOVERY--NUCLEAR &SIGNALING TARGETS$75,572
U19 · FY2000 · CA
ELABORATION OF MODIFIED PROTEINS USING MISACYLATED TRNAS$29,288
R01 · FY2000 · CA